Skip to main content
logo
Initiator Pharma A/S (STO:INIT)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.350
+0.040 (1.73%)
Sep 2, 2026, 5:15 PM CET

Initiator Pharma Financials Overview

Millions DKK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Profit
-29.73-14.83-11.07-23.41-38.43-21.63
Operating Income
-32.22-17.78-14.5-27.03-41.74-23.07
Net Income
-28.2-13.69-12.93-22.87-38.46-21.06
Earnings Per Share
-0.41-0.22-0.23-0.44-0.80-0.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17.0726.2513.3724.3439.1134.35
Total Debt
9.672.15-15.4412.5813.29
Net Cash (Debt)
7.424.113.378.926.5421.06
Net Cash Growth
194.78%80.21%50.25%-66.46%26.02%55.92%
Net Cash Per Share
0.110.390.240.170.550.60

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.56-17.73-12.08-17.65-32.7-34.1
Capital Expenditures
------
Free Cash Flow
-23.56-17.73-12.08-17.65-32.7-34.1
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.0811.2516.597.36-